The levonorgestrel-releasing intrauterine system: Safety, efficacy, and patient acceptability.
The levonorgestrel-releasing intrauterine system (LNG-IUS) is a safe, effective and acceptable form of contraception used by over 150 million women worldwide. It also has a variety of noncontraceptive benefits including treatment for menorrhagia, endometriosis, and endometrial hyperplasia. The LNG-IUS has also been used in combination with estrogen for hormone replacement therapy and as an alternative to hysterectomy. Overall, the system is very well tolerated and patient satisfaction is quite high when proper education regarding possible side effects is provided. However, despite all of the obvious benefits of the LNG-IUS, utilization rates remain quite low in the developed countries, especially in the United States. This is thought to be largely secondary to the persistent negative impressions from the Dalkon Shield intrauterine experience in the 1970s. This history continues to negatively influence the opinions of both patients and health care providers with regards to intrauterine devices. Providers should resolve to educate themselves and their patients on the current indications and uses for this device, as it, and intrauterine contraception in general, remains a largely underutilized approach to a variety of women's health issues.
Beatty
Megan N
MN
Department of Obstetrics and Gynecology, Stanford University, Stanford, CA, USA.
Blumenthal
Paul D
PD
Maturitas. 2007 Jun 20;57(2):210-3
17270370
Fertil Steril. 1997 Sep;68(3):426-9
9314908
Contraception. 1994 Jan;49(1):56-72
8137626
Contraception. 1991 Nov;44(5):473-80
1797462
Eur J Obstet Gynecol Reprod Biol. 2006 Apr 1;125(2):259-64
16246481
Hum Reprod Update. 2008 May-Jun;14(3):197-208
18400840
Am J Obstet Gynecol. 2006 Nov;195(5):1272-7
17074548
N Engl J Med. 2009 Jan 15;360(3):268-79
19144942
Fertil Steril. 2003 Aug;80(2):305-9
12909492
Am J Obstet Gynecol. 2008 Apr;198(4):373.e1-7
18177833
Contraception. 2007 Jun;75(6 Suppl):S2-7
17531612
Contraception. 2003 Jul;68(1):31-4
12878284
Eur J Gen Pract. 2004 Sep;10(3):82-7
15534571
Contraception. 2003 Feb;67(2):87-91
12586318
Lancet. 2001 Feb 10;357(9254):443
11273068
Contraception. 2007 Jun;75(6 Suppl):S55-9
17531618
Eur J Obstet Gynecol Reprod Biol. 2009 Apr;143(2):128-9
19181433
Hum Reprod. 2007 Oct;22(10):2647-52
17652452
Lancet. 2001 Jan 27;357(9252):273-7
11214131
Contraception. 2008 Apr;77(4):227-9
18342643
JAMA. 2002 Jul 17;288(3):321-33
12117397
JAMA. 1998 Aug 19;280(7):605-13
9718051
Contraception. 1999 Sep;60(3):173-5
10640162
Contraception. 2007 Mar;75(3):185-92
17303487
Contraception. 1993 Jul;48(1):1-12
8403900
Br J Obstet Gynaecol. 1998 Jun;105(6):592-8
9647148
Contraception. 2007 Jun;75(6 Suppl):S152-4
17531608
Gynecol Oncol. 2008 Oct;111(1):68-73
18684496
Hum Reprod. 2005 Jul;20(7):1993-8
15790607
Obstet Gynecol. 1992 Jun;79(6):963-7
1579323
Hum Reprod. 2005 Sep;20(9):2653-60
15905289
Obstet Gynecol. 2005 Jan;105(1):223-32
15625179
Aust N Z J Obstet Gynaecol. 2004 Jun;44(3):247-51
15191451
Contraception. 2006 Sep;74(3):249-58
16904420
Obstet Gynecol. 2002 Apr;99(4):608-13
12039121
Hum Reprod. 2005 Mar;20(3):789-93
15608040
Acta Obstet Gynecol Scand. 1999 Sep;78(8):716-21
10468065
Contraception. 2006 Nov;74(5):376-81
17046378
Cochrane Database Syst Rev. 2005 Oct 19;(4):CD002126
16235297
Steroids. 2000 Oct-Nov;65(10-11):693-7
11108878
Am J Obstet Gynecol. 2008 Mar;198(3):248-53
18221924
Contraception. 2007 Oct;76(4):292-6
17900440
Eur J Contracept Reprod Health Care. 1998 Dec;3(4):190-3
10036601
Eur J Obstet Gynecol Reprod Biol. 2008 Aug;139(2):169-75
18440693
Contraception. 2009 Jan;79(1):24-8
19041437
Cochrane Database Syst Rev. 2001;(2):CD001327
11405986
J Fam Plann Reprod Health Care. 2004 Apr;30(2):99-108; quiz 109
15086994
Contraception. 2006 May;73(5):528-31
16627040
Contraception. 1993 Feb;47(2):169-75
8449017
Climacteric. 2000 Sep;3(3):199-211
11910622